A poisoned npm package infected 140+ projects with a hidden payload. This report highlights how to detect, hunt, and defend ...
– NociPro enables highly selective nociceptor targeting and potent Na V 1.7 knockdown in rodents and non-human primates, supporting development candidate ETX301 for post‑amputation neuroma pain – – ...
– ETX301 nominated as a development candidate for post-amputation neuroma pain, with a planned IND submission in 2027 – SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics, Inc.
I never thought smart home tech was for me. Maybe that’s because my introduction to it was largely centered around my friends incessantly yelling “Hey Google!” whenever they wanted a light turned on ...
All the Latest Game Footage and Images from Encode Encore! A charming, slice-of-life indie RPG where you earn some sweet cash by trying out various part-time jobs—all in the name of getting your girl ...
Encoded Therapeutics expects to start a pivotal study of its Dravet syndrome gene therapy ETX101 in 2026. (Getty Images) Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78 ...
An unexpected revisit to my earlier post on mouse encoder hacking sparked a timely opportunity to reexamine quadrature encoders, this time with a clearer lens and a more targeted focus on their signal ...
The original Super Smash Bros. launched in 1999 on the Nintendo 64. Since then, the developers at Nintendo have released several games that built on that original premise of putting everyone’s ...
DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.
Most of the affected roles will be in Encoded's technology and early-stage R&D functions. (iStock / Getty Images Plus) Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy ...
Encoded’s layoffs will mostly affect its technology and early-stage research and development functions. The move is expected to keep the biotech operational well into 2026. To extend its cash runway ...